Podcast: Let’s Start a Medical Affairs Revolution

Warning. Medical Affairs ‘purists’ will be triggered by this podcast.

Like it or not, there is a revolution at hand for medical affairs teams. There will be those who embrace the change and ride the wave to a meaningful, collaborative, cross-functional role in pharma, and those who get left behind in the weeds of 'vanity' metrics and disjointed tactics.

Whether you’re a new or veteran listener to my BioPharma Revolution podcast then you know we’re traveling in the fast lane with the pirates over here. So buckle up because this episode is a treasure chest full of medical affairs plunder.

Our guest is Carlos Eid, Cardiovascular Executive Medical Director at Novartis and  a self-confessed pirate of pharma. I saw him speak at a conference and knew right away that I had to have him on the show… and I’m so happy he accepted.


What to expect from Carlos;

  • Reflections on the past, present and future of medical affairs
  • Challenging our perspective on what makes a brilliant industry medic
  • Understanding how functions can work collaboratively around patient outcomes
  • Learning how AI and technology can optimise real-time analytics and insights
  • Answers to questions over the future value of field medical
  • Lessons on measuring impact beyond vanity metrics and tactical success
  • Practical and valuable medical education journey-planning tips

For links to other episodes in our medical-affairs series, check out ‘From Compliance Fears to Code Clarity’,  ‘How to Fall Back in Love with Medical Affairs’,  and  ‘Integrating Omni-channel Into Medical Affairs’.

Make sure you sign up for updates below because I’ll be producing a WhitePaper for our listeners that summarises all the insights from our medical affairs podcast guests into a comprehensive document that you can share with your colleagues or use to support your own medical affairs journey.


Subscribe to be the first to receive resources for Healthcare Marketing and Medical Affairs teams